Company Filing History:
2 out of 24 
1 out of 1 
1 out of 22 
Years Active: 2009-2011
Title: Kim Hewitt: Innovator in Proliferative Disorder Treatments
Introduction
Kim Hewitt is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating proliferative disorders. With a total of 4 patents to her name, her work continues to impact the medical community.
Latest Patents
Among her latest innovations are the IAP BIR domain binding compounds. These patents disclose isomers, enantiomers, diastereoisomers, or tautomers of a compound represented by Formula I, or a salt thereof. The compounds are designed to treat proliferative disorders, showcasing her commitment to advancing therapeutic options in this critical area.
Career Highlights
Throughout her career, Kim has worked with notable companies such as Aegera Therapeutics, Inc. and Aegera Therapeutics, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research.
Collaborations
Kim has collaborated with esteemed colleagues, including Alain Laurent and Stephen J. Morris. These partnerships have fostered an environment of innovation and creativity, further enhancing her contributions to the field.
Conclusion
Kim Hewitt's work exemplifies the spirit of innovation in the medical field. Her patents and collaborations reflect her dedication to improving treatments for proliferative disorders. Her contributions continue to inspire future advancements in medicinal chemistry.